Send to

Choose Destination
Annu Rev Immunol. 2016 May 20;34:31-64. doi: 10.1146/annurev-immunol-032414-112151.

Mechanisms of Pediatric Inflammatory Bowel Disease.

Peloquin JM1,2,3, Goel G2,3, Villablanca EJ1,2,3, Xavier RJ1,2,3,4,5.

Author information

Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease and.
Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, Massachusetts 02114.
Harvard Medical School, Boston, Massachusetts 02115; email: , , ,
Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142.
Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.


Inflammatory bowel disease (IBD), including Crohn disease and ulcerative colitis, is characterized by chronic intestinal inflammation due to a complex interaction of genetic determinants, disruption of mucosal barriers, aberrant inflammatory signals, loss of tolerance, and environmental triggers. Importantly, the incidence of pediatric IBD is rising, particularly in children younger than 10 years. In this review, we discuss the clinical presentation of these patients and highlight environmental exposures that may affect disease risk, particularly among people with a background genetic risk. With regard to both children and adults, we review advancements in understanding the intestinal epithelium, the mucosal immune system, and the resident microbiota, describing how dysfunction at any level can lead to diseases like IBD. We conclude with future directions for applying advances in IBD genetics to better understand pathogenesis and develop therapeutics targeting key pathogenic nodes.


Crohn disease; genetics; intestinal homeostasis; microbiome; therapeutics; ulcerative colitis

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center